Colonoscopy screening for colorectal cancer in Egypt: a nationwide cross-sectional study
Abdallah R. Allam(Menoufia University), Mohamed A. Gouda(The University of Texas MD Anderson Cancer Center), Ali Abdelaziz(Alexandria University), Mahmoud Tawfik KhallafAllah(Menoufia University), Hamdy Khaled Sabra(Tanta University), Ahmed Hafez Allam(Menoufia University), Yara Mohamed El-Said(Menoufia University), Mohamed Mohamed Shawqi(Benha University), Omar Ali Aboshady(Menoufia University), Ibrahim Kabbash(Tanta University), Ibrahim Tawfiq Daghash(Menoufia University), Mostafa Behery Behery(Menoufia University), Ahmed Monib Eldaboush(Al-Azhar University), Enas Sherif Adwy(Benha University), Rawan Tarek Elweza(Mansoura University), Abdelrahman Elbendary Hammad(Cairo University), Omnia M. Mostafa(South Valley University), M.A. Elsayed(Menoufia University), Ahmed Eid Radwan(Menoufia University), Marwa Ibrahim Ewis(Menoufia University), Noor Maged Badrawy Ahmed(Ain Shams University), Ammar Ayman Bahbah(Menoufia University)
Cited by 12
Related Papers
Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST)
|Annals of Oncology|2023|103
Precision oncology for BRAF-mutant cancers with BRAF and MEK inhibitors: from melanoma to tissue-agnostic therapy
|ESMO Open|2023|101
Expanding the Benefit: Dabrafenib/Trametinib as Tissue-Agnostic Therapy for <i>BRAF</i> V600E–Positive Adult and Pediatric Solid Tumors
|American Society of Clinical Oncology Educational Book|2023|92
ALK fusions in the pan-cancer setting: another tumor-agnostic target?
|npj Precision Oncology|2023|89
The evolving landscape of tissue‐agnostic therapies in precision oncology
|CA A Cancer Journal for Clinicians|2024|68